批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2017/06/15 |
ORIG-1(原始申请) |
Approval |
Type 7 - Drug Already Marketed without Approved NDA |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2022/10/17 |
SUPPL-13(补充) |
Approval |
Labeling-Package Insert,Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2021/12/29 |
SUPPL-11(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/06/17 |
SUPPL-7(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/12/22 |
SUPPL-1(补充) |
Approval |
Labeling-Container/Carton Labels,Labeling-Package Insert |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 004 |
10130646 |
2037/07/25 |
|
Y |
|
|
2025/08/22
|
PDF格式 | |
| 005 |
10130646 |
2037/07/25 |
|
Y |
|
|
2025/08/22
|
PDF格式 | |
与本品治疗等效的药品
>>>活性成分:CALCIUM GLUCONATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:1GM/10ML (100MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 208418 |
001 |
NDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
1GM/10ML (100MG/ML) |
Prescription |
Yes |
Yes |
AP |
2017/06/15
|
FRESENIUS KABI USA |
| 213071 |
001 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2022/10/14
|
NIVAGEN PHARMS INC |
| 216611 |
001 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2024/05/10
|
AMNEAL |
>>>活性成分:CALCIUM GLUCONATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:5GM/50ML (100MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 208418 |
002 |
NDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
5GM/50ML (100MG/ML) |
Prescription |
Yes |
Yes |
AP |
2017/06/15
|
FRESENIUS KABI USA |
| 213071 |
002 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
5GM/50ML (100MG/ML) |
Prescription |
No |
No |
AP |
2023/10/19
|
NIVAGEN PHARMS INC |
| 217689 |
001 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
5GM/50ML (100MG/ML) |
Prescription |
No |
No |
AP |
2023/10/19
|
SOMERSET |
| 216611 |
002 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
5GM/50ML (100MG/ML) |
Prescription |
No |
No |
AP |
2024/05/10
|
AMNEAL |
>>>活性成分:CALCIUM GLUCONATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:10GM/100ML (100MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 208418 |
003 |
NDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
10GM/100ML (100MG/ML) |
Prescription |
Yes |
Yes |
AP |
2017/06/15
|
FRESENIUS KABI USA |
| 216541 |
001 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
10GM/100ML (100MG/ML) |
Prescription |
No |
No |
AP |
2023/08/21
|
B BRAUN MEDICAL |
| 217689 |
002 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
10GM/100ML (100MG/ML) |
Prescription |
No |
No |
AP |
2023/10/19
|
SOMERSET |
| 213071 |
003 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
10GM/100ML (100MG/ML) |
Prescription |
No |
No |
AP |
2024/04/30
|
NIVAGEN PHARMS INC |
| 216611 |
003 |
ANDA |
CALCIUM GLUCONATE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
10GM/100ML (100MG/ML) |
Prescription |
No |
No |
AP |
2024/05/10
|
AMNEAL |
>>>活性成分:CALCIUM GLUCONATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:1GM/50ML (20MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 208418 |
004 |
NDA |
CALCIUM GLUCONATE IN SODIUM CHLORIDE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
1GM/50ML (20MG/ML) |
Discontinued |
Yes |
No |
AP |
2021/06/17
|
FRESENIUS KABI USA |
| 217174 |
001 |
ANDA |
CALCIUM GLUCONATE IN SODIUM CHLORIDE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
1GM/50ML (20MG/ML) |
Prescription |
No |
Yes |
AP |
2023/09/05
|
AMNEAL |
>>>活性成分:CALCIUM GLUCONATE; 剂型/给药途径:SOLUTION;INTRAVENOUS; 规格:2GM/100ML (20MG/ML); 治疗等效代码:AP<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 208418 |
005 |
NDA |
CALCIUM GLUCONATE IN SODIUM CHLORIDE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
2GM/100ML (20MG/ML) |
Discontinued |
Yes |
No |
AP |
2021/06/17
|
FRESENIUS KABI USA |
| 217174 |
002 |
ANDA |
CALCIUM GLUCONATE IN SODIUM CHLORIDE |
CALCIUM GLUCONATE |
SOLUTION;INTRAVENOUS |
2GM/100ML (20MG/ML) |
Prescription |
No |
Yes |
AP |
2023/09/05
|
AMNEAL |